Does AMLODIPINE Cause Peripheral arterial occlusive disease? 19 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 19 reports of Peripheral arterial occlusive disease have been filed in association with AMLODIPINE (Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide). This represents 0.0% of all adverse event reports for AMLODIPINE.
19
Reports of Peripheral arterial occlusive disease with AMLODIPINE
0.0%
of all AMLODIPINE reports
0
Deaths
10
Hospitalizations
How Dangerous Is Peripheral arterial occlusive disease From AMLODIPINE?
Of the 19 reports, 10 (52.6%) required hospitalization.
Is Peripheral arterial occlusive disease Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for AMLODIPINE. However, 19 reports have been filed with the FAERS database.
What Other Side Effects Does AMLODIPINE Cause?
Hypotension (6,504)
Toxicity to various agents (5,554)
Completed suicide (5,267)
Drug ineffective (4,091)
Dyspnoea (3,907)
Dizziness (3,536)
Intentional overdose (3,427)
Fall (3,215)
Fatigue (3,141)
Headache (2,907)
What Other Drugs Cause Peripheral arterial occlusive disease?
NILOTINIB (319)
METHOTREXATE (120)
ADALIMUMAB (116)
RIVAROXABAN (101)
PONATINIB (90)
IMATINIB (86)
ASPIRIN (77)
ATORVASTATIN (70)
METOPROLOL (70)
CALCIUM\DEXTROSE\MAGNESIUM\SODIUM\SODIUM (63)
Which AMLODIPINE Alternatives Have Lower Peripheral arterial occlusive disease Risk?
AMLODIPINE vs AMLODIPINE BESILATE
AMLODIPINE vs AMLODIPINE\ATORVASTATIN
AMLODIPINE vs AMLODIPINE\BENAZEPRIL
AMLODIPINE vs AMLODIPINE\HYDROCHLOROTHIAZIDE\OLMESARTAN
AMLODIPINE vs AMLODIPINE\HYDROCHLOROTHIAZIDE\OLMESARTAN MEDOXOMIL